These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37227711)

  • 1. Association of Metformin With the Development of Age-related Macular Degeneration in the Diabetes Prevention Program Outcomes Study-Reply.
    Domalpally A; Pan Q; Chew EY
    JAMA Ophthalmol; 2023 Jul; 141(7):697. PubMed ID: 37227711
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Metformin With the Development of Age-Related Macular Degeneration in the Diabetes Prevention Program Outcomes Study.
    Asensio-Sánchez VM
    JAMA Ophthalmol; 2023 Jul; 141(7):696. PubMed ID: 37227707
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Metformin With the Development of Age-Related Macular Degeneration.
    Domalpally A; Whittier SA; Pan Q; Dabelea DM; Darwin CH; Knowler WC; Lee CG; Luchsinger JA; White NH; Chew EY;
    JAMA Ophthalmol; 2023 Feb; 141(2):140-147. PubMed ID: 36547967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease latency bias and the protective effect of metformin against age-related macular degeneration.
    Ling JYM; Mansournia MA; Etminan M
    Eye (Lond); 2024 Jun; 38(9):1616-1617. PubMed ID: 38443542
    [No Abstract]   [Full Text] [Related]  

  • 5. Disease latency bias and the protective effect of metformin against age-related macular degeneration.
    Beare N
    Eye (Lond); 2024 Oct; 38(14):2841. PubMed ID: 38734747
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
    Goodarzi MO; Azziz R
    Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
    [No Abstract]   [Full Text] [Related]  

  • 7. The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration.
    Brown EE; Ball JD; Chen Z; Khurshid GS; Prosperi M; Ash JD
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1470-1477. PubMed ID: 30973575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Screening and Prevention of Diabetes Mellitus.
    Martinez LC; Sherling D; Holley A
    Prim Care; 2019 Mar; 46(1):41-52. PubMed ID: 30704659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?
    Scheen AJ
    Diabetes Care; 2003 Sep; 26(9):2701; author reply 2701-3. PubMed ID: 12941752
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic drug-treated patients best suited for metformin therapy. Reply.
    Curtis J; Newall H; Myles N; Shiers D; Samaras K
    Acta Psychiatr Scand; 2013 Dec; 128(6):489. PubMed ID: 23647132
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin for prevention of type 2 diabetes.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2004; 38(7-8):1283-5. PubMed ID: 15150378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oral metformin in preventing and treating age-related macular degeneration: A meta-analysis.
    Elhalag RH; Mohamed MS; Abowafia M; Mourid MR; Mahmoud N; Abourady Y; Ghali P; Moussa MH; Shah J; Motawea KR
    Medicine (Baltimore); 2024 Jul; 103(28):e38728. PubMed ID: 38996175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study.
    Jiang J; Chen Y; Zhang H; Yuan W; Zhao T; Wang N; Fan G; Zheng D; Wang Z
    BMJ Open; 2022 Apr; 12(4):e054420. PubMed ID: 35473747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin for prevention of diabetes?].
    Göke B
    Internist (Berl); 2000 May; 41(5):491. PubMed ID: 10867907
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes: preventing type 2 diabetes mellitus: is metformin the answer?
    Buchanan TA; Xiang AH
    Nat Rev Endocrinol; 2010 May; 6(5):253-4. PubMed ID: 20414319
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin: drug of choice for the prevention of type 2 diabetes and cardiovascular complications in high-risk subjects.
    Standl E
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S121-2. PubMed ID: 14502110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2019 Apr; 42(4):601-608. PubMed ID: 30877090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: prevention of lactic acidosis.
    McNamee M; Bartek JK
    Urol Nurs; 1996 Jun; 16(2):71-2. PubMed ID: 8826161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.